(Received May 18, 1992 . Accepted June 17, 1992) SUMMARY:
Eight T-cell hybridomas were established from the draining lymph node of C3H mice immunized with Semliki forest virus (SFV). Six of them showed specificity toward viral-structure protein E2, while the remaining two clones included one with specificity to an other structural protein E1 and the other with specificity to C. The production of IL-2 by the E2 protein-specific T-cell hybridomas in the presence of SFV was suppressed by treating the antigenpresenting cells (APC) with ammonium chloride raising pH of the acidic compartments.
It was found also that treatment of APC with a thiol protease inhibitor, leupeptin or E64, resulted in a reduced response of some of the E2-specific T-cell hybridomas.
The E2 protein of SFV proved to be resistant at pH 7.0, and sensitive at pH 5.0 to in vitro cathepsin B treatment.
In contrast, the E1 and C proteins proved to be resistant to both pH values. These results indicate that the thiol protease, probably cathepsin B, works as one of the enzymes group involved in antigen processing. INTRODUCTION 
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,
RESULTS

Antigen Specificity of T-cell Hybridomas
We attempted to obtain SFV-specific T-cell hybridomas from the draining lymph node cells of SFV-immunized mice and to determine the viral antigen specificity of each hybridoma. Eight hybridomas exhibited SFV-specific response. Six of them responded to the E2 protein purified by SDS-PAGE, while the remaining two clones consisted of one with specificity to the E1 protein and the other to C protein of SFV. Table I summarizes the antigen specificity of eight hybridomas. All of them were phenotyped as CD4+CD8-by cytofluorograph analysis (data not shown).
Effects o f A mmonium Chloride and Monensin on Antigen Presentation
To clarify the process in which endocytosed SFV is digested in APC and processed as antigen, the effects of ammonium chloride and monensin on the antigen presentation by APC were studied. C3H spleen cells were treated with either of these two agents for 2 hr as described in Materials and Methods, and used as APC. The presentation of SFV antigen by the spleen cells to the SFVspecific AB4-2 T-cell hybridomas was suppressed by treatment of APC with ammonium chloride neutralizing the acidic compartments (Fig. 1) . Monensin, a AC3H murine spleen cells were treated for 30 min with 10 mM ammonium chloride or monensin at the concentration shown in the figure, added with 108 TCID50 of UV-SFV, and cultured for 2 hr. The spleen cells were washed, added with the AB4-2 T-cell hybridomas, and cultured for 48 hr. After culturing, the supernatant was harvested and the IL-2 activities contained therein were measured with CTLL-2 cells (IL-2 dependent cells). The IL-2 activity was calculated from the absorbance of human recombinant IL-2.
carboxylic ionophore also inhibited APC from presenting SFV antigens to AB4-2 T-cell hybridomas.
Effects of Protease Inhibitors on Antigen Presentation
The effects of endopeptidase inhibitors on antigen presentation were studied. APC treated with leupeptin, a thiol-and serine-protease inhibitor, were inhibited in the ability to present UV-SFV antigen to E2 protein-specific AB4-2 T-cell hybridomas. By contrast, the ability of the treated APC to present the antigen to E2 protein-specific AB8-2 T-cell hybridomas was increased. The ability of the treated APC to present the antigen to E2 protein-specific BF12-2 and AB9-2 T-cell hybridomas was not affected (Table II) . To determine which of the two endopeptidases, thiol or serine protease, works in antigen processing of Table I . IL-2 production by T-cell hybridomas in response to Semliki forest virus structual proteins
T-cell hybridomas were tested with Semliki forest virus structual protein eluted from SDS-PAGE and irradiated spleen cells (4 X 105). In 2 days, supernatants were tested for IL-2 by CTLL-2 assay. Table II APC for the presentation of E2 to AB4-2 T-cell hybridomas, spleen cells were treated with E64. E64 is known to suppress the action of thiol such a protease as cathepsin B. The treatment was found to suppress the presentation of SFV antigen to E2 protein-specific AB4-2 T-cell hybridomas (Fig. 2) . Treatment of spleen cells with TLCK slightly suppressed the presentation of SFV antigen to AB4-2 T-cell hybridomas. Treatment of APC with pepstatin (0.025-0.1 mM) or 1.10-phenanthroline, an acidic or metallic protease inhibitor, showed no effect on the presentation of SFV antigen to AB4-2 T-cell hybridomas (Fig. 3) .
These results suggest that the presentation of SFV antigen to SFV E2
protein-specific AB4-2 T-cell hybridomas requires the antigen processing of UV-SFV by thiol such a protease as cathepsin B. C3H murine spleen cells were treated for 30 min with a protease inhibitor (pepstatin or 1-10 phenanthrolin), added with 108 TCID50 of UV-SFV, and cultured for 2 hr. The spleen cells were washed, added with the AB4-2 hybridomas, and cultured for 48 hr. After culturing, the supernatant was harvested and the IL-2 activities contained therein were measured with CTLL-2 cells (IL-2 dependent cells). The IL-2 activity was calculated from the absorbance of human recombinant IL-2.
Differences among El, E2 and C Proteins of SFVin Sensitivity to Cat hepsin B
To determine the sensitivities of SFV-proteins E2, E1, and C to cathepsin B at different pH values, purified SFV samples were first subjected to dialysis overnight at 4 C against the buffer at different pH values, 5.0, 6.0, and 7.0. The dialyzed SFV samples were treated with cathepsin B in the presence of cysteineHCl at 37 C for 20 min and then subjected to SDS-PAGE 7.5% gel, as described in Materials and Methods. As shown in Fig. 4 , the protein band corresponding to E2
protein disappeared in the SFV sample treated with cathepsin B at pH 5.0, while those corresponding to E1 and C proteins remained intact (lane C). The bands of protein to AB4-2 T-cell hybridomas (Fig. 1) . It has been reported that monensin inhibits the intracellular transport of antigen through endosomes and Golgi apparatus (14) and also the antigen presentation by neutralizing acidic vesicles in APC as a lysosomotropic agent (17). It is not clear which function of monensin is working for the inhibition of SFV antigen presentation.
The sensitivity of the protein to protease greatly affects the antigen processing. Leupeptin is a tripeptide competitively inhibiting thiol and serine proteases in the acidic compartments (18) . The study showed that treating with leupeptin leads to a suppression of the antigen presention to AB4-2 T-cell hybridomas, but to an augmentation of the presentation to AB8-2 T-cell hybridomas (Table II) . The protease present in the acidic compartments is known to have two opposite functions, one increases immunogenicity by digesting the protein antigen and the other decreases immunogenicity (19). The finding that the thiol protease activity is reduced on addition of leupeptin may be interpreted in the sense that the resulting antigen fragment in the antigen-presenting cell is not appropriate for its presentation as an antigen on AB4-2 T-cell hybridomas, but is a more effective fragment for presentation on AB8-2 T-cell hybridomas.
This is substantiated by the fact that the response of AB4-2 T-cell hybridomas is inhibited on addition of a thiol protease inhibitor, E64 (Fig. 3) . It is therefore conceivable that AB4-2 T-cell hybridomas have a specific ability to recognize the peptide that is digested by such a thiol protease as cathepsin B in the acidic compartments.
We did not succeed, however, in the activation of AB4-2 T-cell hybridomas by APC pulsed in vitro with the cathepsin B-digested SFV peptides, probably because the concentrations of the peptides used in our experiments were lower than the levels necessary to elicit the desired responses.
Eisenlohr et al. (20) reported that the concentration of antigen necessary for the activation of hybridomas is higher for virus peptide than for whole virus.
Cathepsin B is known to be present in the acidic compartments. E2 protein was resistant against in vitro treatment of SFV for 20 min at pH 6.0 with cathepsin B but sensitive to it at pH 5.0. E1 and C protein, were resistant to digestion at either pH. The early endosome has pH of 6.5-6.2, the sorting endosome pH of 6.2 or lower, the late endosome pH of 5.2-5.8, and the lysosome pH of 4.65 or lower (1,21). Cathepsin B and D are primarily localized in the Iapositive late endosome (22) . This means that APC cannot present the SFV antigen on the AB4-2 hybridomas unless the viral proteins have previously been digested by a thiol protease in the late endosome.
